Guts, your conclusions are 100% correct. However, not knowing the raw material cost, affects the bottom line. It could be higher or lower than your 5-10% estimate. In any event, the result will be positively positive .By the way, PIMD is growing rapidly through its sales of a complete line of diabetic supplies and its offering of many discounted pharmaceuticals to pharmacies. As I previously stated, I believe PIMD will eventually surpass MAV in total sales.
